Bliss GVS Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE416D01022
NSEID: BLISSGVS
BSEID: 506197

INR

173.05

12.95 (8.09%)

BSENSE

Dec 19

BSE+NSE Vol: 1.92 cr

{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "173.05",
    "chg": 12.95,
    "chgp": "8.09%",
    "dir": 1,
    "prev_price": "160.10",
    "mcapval": "1,863.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE416D01022",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "1.92 cr",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Bliss GVS Pharma Sees Exceptional Trading Volumes Amidst Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-surges-on-exceptional-volume-amid-strong-market-momentum-3763791",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BlissGVSPharma_most_active_equities_by_volume_3763791.png",
        "date": "2025-12-19 10:00:19",
        "description": "Bliss GVS Pharma has emerged as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector, registering a remarkable surge in trading volumes and price performance. The stock’s recent activity reflects heightened investor interest, supported by robust market participation and notable price movements over the past few sessions."
      },
      {
        "title": "Bliss GVS Pharma Hits Intraday High with Robust Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-hits-intraday-high-with-856-surge-on-19-dec-2025-3763518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BlissGVSPharma_priceRelatedfactors_3763518.png",
        "date": "2025-12-19 09:32:31",
        "description": "Bliss GVS Pharma demonstrated a strong intraday performance today, surging to an intraday high of Rs 169.7, reflecting a 6% rise within the session. The stock outpaced its sector and broader market indices, supported by heightened volatility and sustained buying interest throughout the day."
      },
      {
        "title": "Bliss GVS Pharma Shows Shift in Price Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-technical-momentum-shifts-signal-bullish-outlook-amid-market-volatility-3763354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BlissGVSPharma_technicaldot_3763354.png",
        "date": "2025-12-19 08:07:41",
        "description": "Bliss GVS Pharma’s recent trading activity reflects a notable shift in price momentum, supported by a range of technical indicators that suggest evolving market dynamics. The stock’s performance contrasts with broader market trends, highlighting a complex interplay of bullish and bearish signals across multiple timeframes."
      },
      {
        "title": "Why is Bliss GVS Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bliss-gvs-pharma-fallingrising-3763045",
        "imagepath": "",
        "date": "2025-12-19 01:47:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Short-Term Price Performance and Technical Indicators</strong></p>\n<p>Bliss GVS Pharma’s stock price demonstrated a notable uptrend on 18 December, outperforming its sector by 10.58% and touching an intraday high of ₹167.55, representing a 15.75% gain within the session. This surge follows a three-day consecutive gain period, during which the stock has appreciated by 11.73%. The stock’s trading range was wide, spanning ₹22.95, indicating heightened volatility and investor interest. Importantly, the stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong technical momentum and positive market sentiment.</p>\n<p>However, it is worth noting that despite the price rally, investor participation has declined, with ..."
      },
      {
        "title": "Bliss GVS Pharma Sees Exceptional Trading Volume Amidst Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-surges-on-exceptional-volume-amid-sector-outperformance-3762684",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BlissGVSPharma_most_active_equities_by_volume_3762684.png",
        "date": "2025-12-18 12:00:07",
        "description": "Bliss GVS Pharma has emerged as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector, registering a remarkable surge in trading volume and price performance. The stock’s recent activity reflects heightened investor interest, supported by a broad-based market momentum and notable price movements within a volatile intraday range."
      },
      {
        "title": "Bliss GVS Pharma Hits Intraday High with Strong Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-hits-intraday-high-with-853-surge-on-18-dec-2025-3762326",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BlissGVSPharma_priceRelatedfactors_3762326.png",
        "date": "2025-12-18 09:57:49",
        "description": "Bliss GVS Pharma recorded a robust intraday performance on 18 Dec 2025, touching a high of Rs 158.6, reflecting a 9.57% rise during the trading session. The stock outpaced its sector peers and demonstrated notable volatility amid a broadly subdued market environment."
      },
      {
        "title": "Bliss GVS Pharma Hits Intraday Low Amid Price Pressure and Market Headwinds",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-hits-intraday-low-amid-price-pressure-on-10-dec-2025-3755410",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BlissGVSPharma_priceRelatedfactors_3755410.png",
        "date": "2025-12-10 14:26:09",
        "description": "Bliss GVS Pharma experienced notable intraday weakness on 10 Dec 2025, touching a low of Rs 150.25 as the stock faced significant price pressure. The decline of 7.42% on the day contrasted sharply with the broader market's more modest movement, reflecting immediate selling pressures and cautious market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bliss GVS Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-technical-momentum-shifts-amid-mixed-market-signals-3752805",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BlissGVSPharma_technicaldot_3752805.png",
        "date": "2025-12-09 08:13:13",
        "description": "Bliss GVS Pharma has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the evolving landscape for this Pharmaceuticals & Biotechnology stock."
      },
      {
        "title": "Is Bliss GVS Pharma overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bliss-gvs-pharma-overvalued-or-undervalued-3747682",
        "imagepath": "",
        "date": "2025-12-05 08:29:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics and Financial Health</strong></p>\n<p>Bliss GVS Pharma trades at a price-to-earnings (PE) ratio of approximately 16.35, which is moderate within the pharmaceutical sector. Its price-to-book value stands at 1.58, indicating the market values the company at nearly one and a half times its net asset value. The enterprise value to EBITDA ratio of 13.26 suggests a reasonable valuation relative to earnings before interest, tax, depreciation, and amortisation.</p>\n<p>Importantly, the company’s PEG ratio is below 1 at 0.92, signalling that its price is not excessively high relative to its earnings growth potential. However, the dividend yield is modest at 0.29%, which may be less attractive to income-focused investors.</p>\n<p>Return on capital employed (ROCE) and return on equity (R..."
      }
    ],
    "total": 276,
    "sid": "730684",
    "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "09-Dec-2025",
      "details": "We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. December 09 2025 has approved the allotment of 66380 equity shares of face value Re.1 /- each to the eligible employees who have exercised their options under Bliss GVS Pharma Limited-Employee Stock Option Plan (Bliss GVS -ESOP 2019)",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "25-Nov-2025",
      "details": "Please find enclosed herewith intimation regarding incorporation of step down wholly owned subsidiary of Bliss GVS Pharma Limited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "24-Nov-2025",
      "details": "Please find enclosed herewith the copies of newspaper advertisement published pertaining to ongoing bi-monthly communications regarding the Special Window for Re-Lodgement of Transfer Requests of Physical Shares.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 24 Jul 25",
          "dt": "2025-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bliss GVS Pharma Sees Exceptional Trading Volumes Amidst Strong Market Momentum

2025-12-19 10:00:19

Bliss GVS Pharma has emerged as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector, registering a remarkable surge in trading volumes and price performance. The stock’s recent activity reflects heightened investor interest, supported by robust market participation and notable price movements over the past few sessions.

Bliss GVS Pharma Hits Intraday High with Robust Trading Momentum

2025-12-19 09:32:31

Bliss GVS Pharma demonstrated a strong intraday performance today, surging to an intraday high of Rs 169.7, reflecting a 6% rise within the session. The stock outpaced its sector and broader market indices, supported by heightened volatility and sustained buying interest throughout the day.

Bliss GVS Pharma Shows Shift in Price Momentum Amid Mixed Technical Signals

2025-12-19 08:07:41

Bliss GVS Pharma’s recent trading activity reflects a notable shift in price momentum, supported by a range of technical indicators that suggest evolving market dynamics. The stock’s performance contrasts with broader market trends, highlighting a complex interplay of bullish and bearish signals across multiple timeframes.

Why is Bliss GVS Pharma falling/rising?

2025-12-19 01:47:25

Strong Short-Term Price Performance and Technical Indicators

Bliss GVS Pharma’s stock price demonstrated a notable uptrend on 18 December, outperforming its sector by 10.58% and touching an intraday high of ₹167.55, representing a 15.75% gain within the session. This surge follows a three-day consecutive gain period, during which the stock has appreciated by 11.73%. The stock’s trading range was wide, spanning ₹22.95, indicating heightened volatility and investor interest. Importantly, the stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong technical momentum and positive market sentiment.

However, it is worth noting that despite the price rally, investor participation has declined, with ...

Bliss GVS Pharma Sees Exceptional Trading Volume Amidst Strong Market Momentum

2025-12-18 12:00:07

Bliss GVS Pharma has emerged as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector, registering a remarkable surge in trading volume and price performance. The stock’s recent activity reflects heightened investor interest, supported by a broad-based market momentum and notable price movements within a volatile intraday range.

Bliss GVS Pharma Hits Intraday High with Strong Trading Momentum

2025-12-18 09:57:49

Bliss GVS Pharma recorded a robust intraday performance on 18 Dec 2025, touching a high of Rs 158.6, reflecting a 9.57% rise during the trading session. The stock outpaced its sector peers and demonstrated notable volatility amid a broadly subdued market environment.

Bliss GVS Pharma Hits Intraday Low Amid Price Pressure and Market Headwinds

2025-12-10 14:26:09

Bliss GVS Pharma experienced notable intraday weakness on 10 Dec 2025, touching a low of Rs 150.25 as the stock faced significant price pressure. The decline of 7.42% on the day contrasted sharply with the broader market's more modest movement, reflecting immediate selling pressures and cautious market sentiment within the Pharmaceuticals & Biotechnology sector.

Bliss GVS Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-09 08:13:13

Bliss GVS Pharma has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the evolving landscape for this Pharmaceuticals & Biotechnology stock.

Is Bliss GVS Pharma overvalued or undervalued?

2025-12-05 08:29:01

Valuation Metrics and Financial Health

Bliss GVS Pharma trades at a price-to-earnings (PE) ratio of approximately 16.35, which is moderate within the pharmaceutical sector. Its price-to-book value stands at 1.58, indicating the market values the company at nearly one and a half times its net asset value. The enterprise value to EBITDA ratio of 13.26 suggests a reasonable valuation relative to earnings before interest, tax, depreciation, and amortisation.

Importantly, the company’s PEG ratio is below 1 at 0.92, signalling that its price is not excessively high relative to its earnings growth potential. However, the dividend yield is modest at 0.29%, which may be less attractive to income-focused investors.

Return on capital employed (ROCE) and return on equity (R...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

09-Dec-2025 | Source : BSE

We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. December 09 2025 has approved the allotment of 66380 equity shares of face value Re.1 /- each to the eligible employees who have exercised their options under Bliss GVS Pharma Limited-Employee Stock Option Plan (Bliss GVS -ESOP 2019)

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

25-Nov-2025 | Source : BSE

Please find enclosed herewith intimation regarding incorporation of step down wholly owned subsidiary of Bliss GVS Pharma Limited.

Announcement under Regulation 30 (LODR)-Newspaper Publication

24-Nov-2025 | Source : BSE

Please find enclosed herewith the copies of newspaper advertisement published pertaining to ongoing bi-monthly communications regarding the Special Window for Re-Lodgement of Transfer Requests of Physical Shares.